ETON - Eton Pharmaceuticals, Inc. Summary, Stock Quote and News | Benzinga

Skip to main content

Market Overview

7.910 -0.18 (-2.22%)

Data as of May 09, 2021

Prev. Close 8.09
Price Open 8.16
Volume 171,359
Day's Range 7.68 - 8.19
52 Wk Range 4.325 - 10.3
50 Day Moving Avg. 7.83
PE Ratio
Shares Outstanding 24.48M
Market Cap 193.66M

Trade ETON stock for free with recommended broker TD Ameritrade.

Analyst Rating View All Ratings

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings Shanthi RexalineSun, 09 May 2021 10:20:32 -0400
Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates Shanthi RexalineSat, 01 May 2021 11:43:34 -0400
42 Biggest Movers From Yesterday Lisa LevinFri, 16 Apr 2021 06:07:11 -0400
Mid-Afternoon Market Update: Gold Jumps 1.8%; Dell Shares Spike Higher Lisa LevinThu, 15 Apr 2021 14:43:15 -0400
Eton Pharmaceuticals On Apr. 8 Entered Underwriting Agreement With National Securities Corporation And Harrow Health Relating To Public Offering Of 1.32M Shares By Harrow Bill HaddadThu, 08 Apr 2021 08:12:02 -0400
HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Lowers Price Target to $14 Benzinga NewsdeskWed, 17 Mar 2021 06:47:41 -0400
Eton Pharmaceuticals Q4 EPS $(0.32) Misses $(0.26) Estimate, Sales $81.00K Miss $1.33M Estimate Benzinga NewsdeskTue, 16 Mar 2021 16:02:25 -0400
The Daily Biotech Pulse: Fulgent Nabs CDC Contract, Enzo Rallies, Solid Biosciences Releases Gene Therapy Data, Moderna Begins Pediatric Vaccine Study Shanthi RexalineTue, 16 Mar 2021 08:17:20 -0400
Earnings Scheduled For March 16, 2021 Benzinga InsightsTue, 16 Mar 2021 04:46:43 -0400
Week Ahead In Biotech (March 14-20): Update On Fibrogen-AstraZeneca's Anemia Drug, Earnings and Presentations Shanthi RexalineSun, 14 Mar 2021 08:14:57 -0400
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Eton Pharmaceuticals to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021 Globe Newswire4 days ago
Eton Pharmaceuticals Announces Appointment of Jenn Adams to its Board of Directors Globe NewswireMar 17, 2021
Eton Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Financial Results Globe NewswireMar 16, 2021
Eton Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIREMar 16, 2021
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results on Tuesday, March 16, 2021 Globe NewswireMar 04, 2021
Eton Pharmaceuticals to Participate in 10th Annual SVB Leerink Global Healthcare Conference Globe NewswireFeb 16, 2021
Eton Pharmaceuticals Announces Sale of Neurology Portfolio Globe NewswireFeb 08, 2021
Eton Pharmaceuticals Announces Acquisition of Canadian Rights for ALKINDI® SPRINKLE Globe NewswireJan 14, 2021
Eton Pharmaceuticals Announces Acceptance for Filing of New Drug Application for Topiramate Oral Solution Globe NewswireDec 17, 2020
Eton Pharmaceuticals Announces Availability of Orphan Drug ALKINDI® SPRINKLE (hydrocortisone) in the United States Globe NewswireNov 24, 2020
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Eton Pharmaceuticals, Inc. (ETON) CEO Sean Brynjelsen on Q4 2020 Results - Earnings Call Transcript Seeking AlphaMar 16, 2021
Eton Pharmaceuticals offloads its neurology portfolio to Azurity Pharma Seeking AlphaFeb 08, 2021
Eton Pharmaceuticals, Inc. (ETON) CEO Sean Brynjelsen on Q3 2020 Results - Earnings Call Transcript Seeking AlphaNov 12, 2020
Eton Pharma files U.S. marketing application for topiramate oral solution Seeking AlphaOct 06, 2020
The Week Ahead In Biotech: Avenue's FDA Decision, Alkermes Adcom Meeting, Aziyo Biologics IPO TalkMarketsOct 04, 2020
FDA OKs Eton Pharma's hydrocortisone as replacement therapy in pediatric adrenocortical insufficiency Seeking AlphaSep 29, 2020
The Week Ahead In Biotech: FDA Decisions For Mesoblast And Eton, Coronavirus Vaccine Updates TalkMarketsSep 26, 2020
NKLA, BCS among premarket losers Seeking AlphaSep 21, 2020
Eton Pharma says 'no decision yet' from FDA for its allergic conjunctivitis med Seeking AlphaSep 16, 2020
The Week Ahead In Biotech: Decision Day For Bausch Health, IPO Flow Resumes, Oncology Conference TalkMarketsSep 13, 2020
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Powered by StockSnips

72.53% Positive

Earnings View Earnings

Q4 2020	EST	Actual	Surprise
EPS:	-0.260	-0.320	-0.0600
Rev:	1.33M	81.00K	-1.25M

Q1 2021	EST	Actual	Surprise
EPS:	0.190	Expected 2021-05-13
Rev:	12.05M	Expected 2021-05-13

Start Investing

The Best Online Stock Trading Brokers

Best Free Stock Trading Brokers

Best Forex Brokers

Best Futures Brokers

How to Invest in Real Estate

Best Day Trading Courses